Medical Devices
-
J&J starts head-to-head PFA trial against Boston Scientific device
The study will compare outcomes on J&J’s Varipulse Pro platform and Boston Scientific’s rival Farapulse PFA system.
By Nick Paul Taylor • April 28, 2026 -
Zimmer Biomet CFO departs for new job
Suketu Upadhyay is headed to biopharma company Incyte. Paul Stellato will step into the CFO role on an interim basis.
By Susan Kelly • April 28, 2026 -
Explore the Trendline➔
Getty Images
TrendlineMedical device industry continues to turn to AI
While the industry continues to embrace artificial intelligence, there are still questions about how the new technologies need to be regulated and if they are effective.
By MedTech Dive staff -
4 studies to know from HRS 2026
Boston Scientific, Abbott and Medtronic shared new cardiac device data at the annual Heart Rhythm Society meeting, where market share shifts in pulsed field ablation were on analysts’ minds.
By Susan Kelly • April 27, 2026 -
J&J to acquire Atraverse Medical
The FDA-cleared radiofrequency guidewire will slot into J&J’s fast-growing cardiovascular portfolio.
By Nick Paul Taylor • April 27, 2026 -
Profile
With ultrasound on a chip, Butterfly Network aims for global reach
Butterfly, which makes handheld imaging machines, hopes to make the technology accessible to more patients with its pricing and AI features.
By Elise Reuter • April 27, 2026 -
Edwards raises 2026 forecast as TAVR sales surge
The stronger outlook follows mixed results from other major medical device makers in the latest quarter, after both Abbott and Boston Scientific cut their full-year guidance.
By Susan Kelly • April 24, 2026 -
J&J lands CE mark for surgical stapler that works with Ottava robot
Johnson & Johnson sees surgeons’ familiarity with Ethicon devices as a differentiator as it enters a robot market dominated by Intuitive Surgical.
By Nick Paul Taylor • April 24, 2026 -
Tandem recalls Mobi insulin pumps over software malfunction
A malfunction may cause insulin delivery to stop. Tandem instructed users to update their pump software as soon as possible.
By Elise Reuter • April 22, 2026 -
CDRH Director Tarver previews AI guidance at AAMI event
Michelle Tarver said the device center plans to finalize guidance on AI lifecycle management and provide some initial thoughts on generative AI following an advisory committee meeting last year.
By Elise Reuter • April 22, 2026 -
Intuitive Surgical lifts 2026 outlook for da Vinci robot procedure growth
The company, whose shares climbed nearly 8% Wednesday morning, also said a recent cyber incident has been contained and did not significantly affect first-quarter results.
By Susan Kelly • April 22, 2026 -
Apple fends off Masimo challenge to Apple Watch redesign
Apple can continue selling redesigned Apple Watches with a blood oxygen feature after the International Trade Commission concluded the products do not infringe Masimo patents.
By Susan Kelly • April 22, 2026 -
Medtronic leads $100M investment in Pulnovo Medical
Medtronic formed a commercial agreement with Pulnovo alongside its investment.
By Nick Paul Taylor • April 21, 2026 -
Medtronic closes $585M purchase of CathWorks
The deal is the second tuck-in acquisition this year for Medtronic, which has signaled its intent to pursue more M&A in its core business lines.
By Susan Kelly • April 20, 2026 -
Sponsored by Veeva MedTech
LTS Lohmann builds a foundation for proactive quality and innovation
How LTS Lohmann unified global quality data to eliminate silos and accelerate innovation.
April 20, 2026 -
Siemens plans shareholder vote on Siemens Healthineers spinoff
The German parent, which is giving up its majority stake in Siemens Healthineers, said preparations for the transaction are progressing toward a vote at its February annual meeting.
By Susan Kelly • April 17, 2026 -
GE HealthCare, RadNet expand AI mammography collaboration
The partnership adds access to a workflow for second reads of complex cases and other software features made by RadNet subsidiary DeepHealth.
By Elise Reuter • April 17, 2026 -
CMS proposes repeal of add-on payment path for breakthrough devices
The Centers for Medicare and Medicaid Services said it developed concerns about the limited evaluation process for the devices after gaining experience with the alternative pathway.
By Susan Kelly • April 17, 2026 -
Abbott lowers earnings forecast after $21B Exact Sciences buy
CEO Robert Ford said the companies are a good cultural fit and he expects demand for Exact’s colon cancer screening test to increase.
By Elise Reuter • April 16, 2026 -
Boston Scientific plans $88.5M R&D expansion in Ireland
The device maker plans to invest 75 million euros into expanding the site, with a focus on cardiovascular innovation.
By Elise Reuter • April 16, 2026 -
Medtronic confirms paclitaxel balloon’s efficacy in post-approval trial
The end-stage kidney disease device performed as well in the study as in a pivotal trial that supported FDA approval.
By Nick Paul Taylor • April 16, 2026 -
Stereotaxis to buy Robocath for up to $45M
The deal combines Stereotaxis’ magnetic navigation technology and Robocath’s mechanical robotic system, strengthening the company’s position in endovascular surgery, said CEO David Fischel.
By Susan Kelly • April 15, 2026 -
AIP to acquire Avanos Medical in $1.27B go-private deal
Avanos Medical generated $701.2 million last year from sectors where it competes with Boston Scientific, Medtronic and Stryker.
By Nick Paul Taylor • April 15, 2026 -
Medline recalls angiographic syringes, receives FDA warning letter
The company removed the devices from the market in February following complaints of the syringes disconnecting from manifolds.
By Elise Reuter • April 14, 2026 -
GE HealthCare integrates ultrasound into Medtronic’s Stealth AXiS surgical system
Partnering with GE HealthCare has enabled Medtronic to provide live images to help surgeons assess mid-procedure changes.
By Nick Paul Taylor • April 13, 2026 -
Stryker to buy Amplitude Vascular Systems
Amplitude’s intravascular lithotripsy technology could emerge as a challenger to Shockwave IVL, Leerink Partners analyst Mike Kratky wrote.
By Elise Reuter • April 13, 2026